Showing results (811-820 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|February 4, 2022
Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON-HFAlexander Peikert, Muthiah Vaduganathan, Finnian Mc Causland, et al.
European Journal of Heart Failure|September 13, 2012
Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-β1-adrenergic receptor antibody neutralization and of immune parametersGötz Münch, Valerie Boivin-Jahns, Hans-Peter Holthoff, et al.
European Journal of Heart Failure|August 8, 2012
Coronary telangiectasia associated with hypertrophic cardiomyopathyAndrea Frustaci, Gerolamo Lanfranchi, Milena Bellin, et al.
European Journal of Heart Failure|August 9, 2012
Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trialDaniela Dobre, Patrick Rossignol, Jan Murin, et al.
European Journal of Heart Failure|September 20, 2012
Quality of life and survival in patients with heart failureTialda Hoekstra, Tiny Jaarsma, Dirk J van Veldhuisen, et al.
European Journal of Heart Failure|September 11, 2012
Utility of lung ultrasound in predicting pulmonary and cardiac pressuresElke Platz, AnnMarie Lattanzi, Chioma Agbo, et al.
European Journal of Heart Failure|June 28, 2012
Resting heart rate and incident heart failure in apparently healthy men and women in the EPIC-Norfolk studyRoman Pfister, Guido Michels, Stephen J Sharp, et al.
European Journal of Heart Failure|July 31, 2012
Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesityAndrea Baessler, Christina Strack, Elena Rousseva, et al.
European Journal of Heart Failure|July 31, 2012
Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device supportSjoukje I Lok, Bjorn Winkens, Roel Goldschmeding, et al.
European Journal of Heart Failure|June 21, 2012
Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromesMihai Gheorghiade, Stephen J Greene, Gerasimos Filippatos, et al.
Pageof 398